Found: 38
Select item for more details and to access through your institution.
Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 2, p. 351, doi. 10.1007/s00432-021-03834-w
- By:
- Publication type:
- Article
Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 5, p. 1481, doi. 10.1007/s00432-020-03430-4
- By:
- Publication type:
- Article
Positron Emission Tomography with 18-Fluorodeoxyglucose in the Staging and Follow-up of Lymphoma in the Chest.
- Published in:
- Acta Oncologica, 1999, v. 38, n. 6, p. 799, doi. 10.1080/028418699432969
- By:
- Publication type:
- Article
Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 888, doi. 10.1111/bjh.16462
- By:
- Publication type:
- Article
Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 2, p. 279, doi. 10.1111/bjh.14764
- By:
- Publication type:
- Article
Differenzialdiagnose BCR-ABL1-negativer myeloproliferativer Neoplasien Differential diagnosis of BCR-ABL1-negative myeloproliferative neoplasms.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 2015, v. 39, n. 5, p. 301, doi. 10.1515/labmed-2015-0079
- By:
- Publication type:
- Article
FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053190
- By:
- Publication type:
- Article
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN).
- Published in:
- Annals of Hematology, 2024, v. 103, n. 8, p. 2775, doi. 10.1007/s00277-024-05867-w
- By:
- Publication type:
- Article
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 7, p. 2299, doi. 10.1007/s00277-024-05665-4
- By:
- Publication type:
- Article
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 349, doi. 10.1007/s00277-022-05080-7
- By:
- Publication type:
- Article
Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 11, p. 2707, doi. 10.1007/s00277-021-04647-0
- By:
- Publication type:
- Article
Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2015, doi. 10.1007/s00277-020-04350-6
- By:
- Publication type:
- Article
Thromboembolic events in polycythemia vera.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 1, p. 93, doi. 10.1007/s00277-018-3483-6
- By:
- Publication type:
- Article
Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Current and future treatment options for polycythemia vera.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 6, p. 901, doi. 10.1007/s00277-015-2357-4
- By:
- Publication type:
- Article
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)
- Published in:
- Annals of Hematology, 2014, v. 93, n. 12, p. 1953, doi. 10.1007/s00277-014-2224-8
- By:
- Publication type:
- Article
Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II study.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 7, p. 907, doi. 10.1007/s00277-013-1725-1
- By:
- Publication type:
- Article
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4086, doi. 10.3390/cancers13164086
- By:
- Publication type:
- Article
Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO)
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2905, doi. 10.3390/cancers13122905
- By:
- Publication type:
- Article
Ruxolitinib-Associated Infections in Polycythemia Vera: Review of the Literature, Clinical Significance, and Recommendations.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3132, doi. 10.3390/cancers12113132
- By:
- Publication type:
- Article
Bleeding complications in bcr‐abl‐negative myeloproliferative neoplasms (MPN): A retrospective single‐center study of 829 MPN patients.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 2, p. 154, doi. 10.1111/ejh.13721
- By:
- Publication type:
- Article
The management, outcome, and postpartum disease course of 41 pregnancies in 20 women with polycythemia vera.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 122, doi. 10.1111/ejh.13627
- By:
- Publication type:
- Article
Recommendations for the diagnosis and treatment of patients with polycythaemia vera.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 654, doi. 10.1111/ejh.13156
- By:
- Publication type:
- Article
Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 2, p. 192, doi. 10.1111/ejh.12707
- By:
- Publication type:
- Article
Options in the management of essential thrombocythaemia.
- Published in:
- European Journal of Haematology, 2007, v. 79, p. 35, doi. 10.1111/j.1600-0609.2007.00943.x
- By:
- Publication type:
- Article
Efficacy and Safety of Cytoreductive Therapies in Patients with Essential Thrombocythaemia Aged >80 Years: An Interim Analysis of the EXELS Study.
- Published in:
- Clinical Drug Investigation, 2013, v. 33, n. 1, p. 55, doi. 10.1007/s40261-012-0042-0
- By:
- Publication type:
- Article
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 558, doi. 10.1002/hon.2898
- By:
- Publication type:
- Article
Defining targets in myeloproliferative disorders: reflecting on what is important.
- Published in:
- Hematological Oncology, 2009, v. 27, n. S1, p. 2, doi. 10.1002/hon.909
- By:
- Publication type:
- Article
A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Clinical course of haemodialysis patients with malignancies and dose-adjusted chemotherapy.
- Published in:
- Nephrology Dialysis Transplantation, 2005, v. 20, n. 6, p. 1187, doi. 10.1093/ndt/gfh807
- By:
- Publication type:
- Article
Diagnosis of Granulocytic Sarcoma by Fine-Needle Aspiration Cytology.
- Published in:
- Acta Haematologica, 2000, v. 103, n. 2, p. 102, doi. 10.1159/000041028
- By:
- Publication type:
- Article
Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leukämien (KNL).
- Published in:
- Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2016, v. 59, n. 4, p. 444, doi. 10.1007/s00103-016-2315-x
- By:
- Publication type:
- Article
Thrombopoietin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remission.
- Published in:
- British Journal of Haematology, 1998, v. 100, n. 3, p. 571, doi. 10.1046/j.1365-2141.1998.00590.x
- By:
- Publication type:
- Article